United States Professional & Commercial Services

DICE Therapeutics Inc (DICE)

Track

Ticker: DICE Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for DICE Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 22 Jun 2023
Value US$2,506,366.15 | Price 129.72 | Shares 51,926 (-16.7%)
Sale 22 Jun 2023
Value US$3,087,411.96 | Price 283.84 | Shares 96,429 (-49.8%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-06-23 2023-06-22 S Sale
Northpond Ventures GP, LLC
Large shareholder
51,926 -16.7%
129.72
US$2,506,366 		51,926 -16.7% 129.72 US$2,506,366
2023-06-23 2023-06-22 S Sale
Northpond Ventures GP, LLC
Large shareholder
96,429 -49.8%
283.84
US$3,087,412 		96,429 -49.8% 283.84 US$3,087,412
2023-06-02 2023-06-01 PlS Planned sale
Jacobsen John R.

CSO

Officer
60,973 -11.7%
109.36
US$2,482,695 		60,973 -11.7% 109.36 US$2,482,695
2023-06-02 2023-06-01 PlS Planned sale
Jacobsen John R.

CSO

Officer
14,307 -8.6%
30.31
US$433,645 		14,307 -8.6% 30.31 US$433,645
2023-05-09 2023-05-05 PlS Planned sale
2.4
SCHELLER RICHARD H
Non-Executive Director
84,097 -90.9%
38.51
US$3,238,205 		84,097 -90.9% 38.51 US$3,238,205
2023-05-05 2023-05-05 PrS Proposed sale
2.4
RICHARD SCHELLER

Director

Non-Executive Director
84,097
38.51
US$3,238,575 		84,097 38.51 US$3,238,575
2023-05-05 2023-05-03 PlS Planned sale
Robertson Scott M.

CFO & CBO

Officer
18,750 -8.7%
36.55
US$685,350 		18,750 -8.7% 36.55 US$685,350
2023-05-05 2023-05-03 PlS Planned sale
Judice Kevin

CEO

Executive Director
13,698 -1.7%
36.50
US$499,977 		13,698 -1.7% 36.50 US$499,977
2023-05-05 2023-05-03 PlS Planned sale
Timothy Lu

CMO

Officer
10,000 -6.2%
36.54
US$365,398 		10,000 -6.2% 36.54 US$365,398
2023-05-03 2023-05-03 PrS Proposed sale
Judice Kevin

Officer; CEO & Founder

Officer
13,698
36.50
US$499,977 		13,698 36.50 US$499,977
2023-05-03 2023-05-03 PrS Proposed sale
Timothy Lu

affiliate
20,000
34.39
US$687,800 		20,000 34.39 US$687,800
2023-05-03 2023-05-03 PrS Proposed sale
Scott Robertson

affiliate
37,500
34.39
US$1,289,625 		37,500 34.39 US$1,289,625
2023-04-19 2023-04-18 PlS Planned sale
Jacobsen John R.

CSO

Officer
16,392 -9.0%
30.08
US$493,127 		16,392 -9.0% 30.08 US$493,127
2023-04-04 2023-03-31 PlS Planned sale
Jacobsen John R.

CSO

Officer
773 -0.4%
30.00
US$23,190 		773 -0.4% 30.00 US$23,190
2023-03-30 2023-03-30 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
195,997 +2.9%
28.74
US$5,632,954 		195,997 +2.9% 28.74 US$5,632,954
2023-03-30 2023-03-29 PlS Planned sale
Jacobsen John R.

CSO

Officer
1,094 -0.6%
30.00
US$32,823 		1,094 -0.6% 30.00 US$32,823
2023-03-30 2023-03-29 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
66,369 +1.0%
29.38
US$1,949,921 		66,369 +1.0% 29.38 US$1,949,921
2023-03-30 2023-03-28 PlS Planned sale
Jacobsen John R.

CSO

Officer
500 -0.3%
30.09
US$15,044 		500 -0.3% 30.09 US$15,044
2023-03-30 2023-03-28 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
246,779 +3.8%
29.24
US$7,215,818 		246,779 +3.8% 29.24 US$7,215,818
2023-03-27 2023-03-27 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
151,132 +2.4%
27.48
US$4,153,107 		151,132 +2.4% 27.48 US$4,153,107
2023-03-27 2023-03-24 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
192,335 +3.1%
26.87
US$5,168,041 		192,335 +3.1% 26.87 US$5,168,041
2023-03-27 2023-03-23 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
155,089 +2.6%
26.67
US$4,136,224 		155,089 +2.6% 26.67 US$4,136,224
2023-03-21 2023-03-17 S Sale
1.8
Scopa James Paul
Non-Executive Director
10,000 -29.7%
29.05
US$290,500 		10,000 -29.7% 29.05 US$290,500
2022-10-19 2022-10-17 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
1,640,000 +31.5%
36.50
US$59,860,000 		1,640,000 +31.5% 36.50 US$59,860,000
Explore more

More insider trading research around DICE Therapeutics Inc

More insider trades in United States
Similar Industrials companies with insider activity
More Industrial & Commercial Services companies with insider activity
More Professional & Commercial Services companies with insider activity
Insider trading in North America